Marker Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Marker Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Marker Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Marker Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $20 | 23 | 0.91 |
| 2025-03-31 | $43 | 36 | 1.22 |
| 2024-12-31 | $119 | 38 | 3.13 |
| 2024-09-30 | $106 | 38 | 2.80 |
| 2024-06-30 | $205 | 38 | 5.40 |
| 2024-03-31 | $164 | 38 | 4.33 |
| 2023-12-31 | $181 | 33 | 5.50 |
| 2023-09-30 | $3.8k | 834 | 4.60 |
| 2023-06-30 | $381 | 123 | 3.10 |
| 2023-03-31 | $0 | 123 | 0.00 |